文献速递肿瘤 PET/CT骨显像与常规 SPECT

18F-FDG摄取在早期辅助化疗期间预测儿童及年轻成人骨肉瘤的组织学反应

18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma.
PubMed 文献 · J Nucl Med · 2017-06-13

本研究在单一机构治疗试验中,对34例新诊断骨肉瘤的儿童及年轻成人患者进行基线和治疗开始后5周、10周的系列18F-FDG PET/CT显像,分析原发肿瘤SUVmax及其变化与组织学反应和无事件生存的关系。逻辑回归显示第5周SUVmax(P=0.034)、第10周SUVmax(P=0.022)及第10周较基线变化百分比(P=0.021)对组织学反应有高度预测性。结论认为这些代谢指标可能有助于早期识别反应不佳、可能受益于治疗改变的患者。

要点

  • 34例新诊断骨肉瘤患者接受基线和治疗开始后5周、10周的系列18F-FDG PET/CT显像。
  • 第5周SUVmax(P=0.034)、第10周SUVmax(P=0.022)及第10周较基线变化百分比(P=0.021)预测组织学反应。
  • 以第5周SUVmax 4.04、第10周SUVmax 3.15、第10周较基线下降60%为界值,敏感度分别为0.93、0.93、0.79,特异度分别为0.53、0.71、0.76。

核心结论

  • 常规图像上第5周或第10周的SUVmax以及从基线到第10周SUVmax的变化百分比是骨肉瘤组织学反应的代谢预测指标。
  • 这些发现可能有助于早期识别对治疗反应不佳、可能受益于治疗改变的患者。

研究设计与样本

  • 在单一机构的一项治疗试验中统一治疗的新诊断骨肉瘤儿童及年轻成人患者,进行基线和治疗开始后5周、10周的系列18F-FDG PET/CT显像。
  • 共34例患者(17例男性;中位年龄12.2岁;年龄范围6.8-19.1岁)接受PET显像;25例(74%)为局限性疾病。
  • 原发肿瘤部位包括股骨(n=17;50%)、胫骨(n=9;26%)和肱骨(n=5;15%)。
  • 全身图像在注射18F-FDG后约1小时获得。
  • 采用逻辑回归研究肿瘤摄取及0、5、10周之间SUVmax变化与两个临床终点的关联。

主要发现

  • 逻辑回归显示第5周SUVmax(P=0.034)、第10周SUVmax(P=0.022)及第10周较基线变化百分比(P=0.021)对组织学反应有高度预测性。
  • 以第5周SUVmax 4.04为界值,敏感度为0.93,特异度为0.53。
  • 以第10周SUVmax 3.15为界值,敏感度为0.93,特异度为0.71。
  • 以第10周较基线下降60%为界值,敏感度为0.79,特异度为0.76。

关键数值与推荐

  • 第5周SUVmax界值4.04:敏感度0.93,特异度0.53。
  • 第10周SUVmax界值3.15:敏感度0.93,特异度0.71。
  • 第10周较基线下降60%界值:敏感度0.79,特异度0.76。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The purpose of this study was to determine the relationship of 18F-FDG uptake in the primary tumor at diagnosis, during therapy, and after therapy with a histologic response and event-free survival in pediatric and young adult patients with osteosarcoma (OS). Methods: Serial (baseline and 5 and 10 wk after start of therapy) 18F-FDG PET/CT imaging was performed in patients with newly diagnosed OS treated uniformly in a therapeutic trial at a single institution. Whole-body images were obtained approximately 1 h after injection of 18F-FDG. Logistic regression was used to study the association of tumor uptake and changes in SUVmax between 0, 5, and 10 wk for both clinical endpoints. Results: Thirty-four patients (17 males; median age, 12.2 y; age range, 6.8-19.1 y) underwent PET imaging; 25 (74%) had localized disease. Primary tumor locations included the femur (n = 17; 50%), tibia (n = 9; 26%), and humerus (n = 5; 15%). Logistic regression showed that SUVmax at 5 wk (P = 0.034) and 10 wk (P = 0.022) and percentage change from baseline at 10 wk (P = 0.021) were highly predictive of a histologic response. Using SUVmax of 4.04 at week 5, SUVmax of 3.15 at week 10, and 60% decrease from baseline at week 10 as cutoff values, we determined that the respective sensitivities were 0.93, 0.93, and 0.79 and that the respective specificities were 0.53, 0.71, and 0.76. Conclusion: SUVmax on routine images at 5 or 10 wk and percentage change in SUVmax from baseline to week 10 were metabolic predictors of a histologic response in OS. These findings may be useful in the early identification of patients who are responding poorly to therapy and may benefit from a change in treatment.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Davis JC, Daw NC, Navid F, et al. 18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma. J Nucl Med. 2017. PMID: 28611244. doi:10.2967/jnumed.117.190595

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。